Our work is entirely funded by private donations – we receive no money from government. Your money will help us continue funding research into vitiligo and supporting people affected by the condition.
116 listed sites: Argentina (5); Canada (9); Colombia (2); Czechia (3); Estonia (2); France (22); Germany (21); Greece (6); Italy (3); Japan (4); Latvia (1); Puerto Rico (3); Romania (7); South Korea (2); Spain (6); Switzerland (10); Taiwan (2); United Kingdom (8) - 02 Sep `25Daily burden of vitiligo and other skin diseases
Daily burden of vitiligo and other skin diseases
Official title: Multi-Country, Cross-sectional Study to Characterize Real World Burden of Disease in Adolescent and Adult Patients With Alopecia Areata, Vitiligo or Hidradenitis Suppurativa (MEASURE AAVitHS)
Status: Recruiting now
Description:
AbbVie plans to enroll about 2,795 participants. This is an observational study, so researchers will not assign an experimental treatment. Researchers are measuring how vitiligo and two other skin conditions affect symptoms, daily life, work, and health care use. Participants may complete exams, questionnaires, record reviews, imaging, or sample collection; no drug-related side effects are expected unless they are already receiving routine treatment. People age 12 and older may qualify. The study is recruiting at 116 listed sites across 18 countries.
Start date: September 02, 2025
Completion date: August 01, 2027
Organizer: AbbVie
Contact: Beth Rycroft
Tel.: 844-663-3742
Email: beth.rycroft@abbvie.com
Clinical Trial Alerts
Sign up and be the first to know about updates on this trial.
FAQOther Questions
- Can Ginkgo Biloba help with vitiligo?
Ginkgo Biloba offers a promising, simple, and relatively affordable option for managing vitiligo. Known for its anti-inflammatory, immunomodulatory, and antioxidant properties, ...
- Does halo nevi affect vitiligo development?
Halo nevi (also known as Sutton's nevi) are characterized by a mole that's surrounded by a ring of depigmented or lighter skin. While both halo nevi and vitiligo involve the des...
- Polypodium leucotomos as an adjunct treatment for vitiligo?
The tropical fern Polypodium leucotomos (also known as Polypodium aureum) and its relative Polypodium decumanumhave shown potential benefits for managing vitiligo and other auto...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.